Report, Document

Investment in General Practice in Wales for 2016 to 2017 financial year to 2020 to 2021 financial year

The report details the Government’s investment in General Practice for 2016 to 2017 financial year to 2020 to 2021 financial year.

First published: 12 January 2022

Last updated: 12 January 2022

This file may not be fully accessible.

In this page

The figures include expenditure relating to dispensing by GP practices. They do not include the costs of drugs dispensed by high street pharmacies.

Table 2a: Summary of reported investment from 2016 to 2021
					£ thousands
	2016/2017	2017/2018	2018/2019	2019/2020	2020/2021
Global sum/MPIG	262,886	274,362	295,599	300,022	308,864
Quality	42,338	42,334	42,337	50,224	47,631

Direct enhanced services (GMS)	21,441	24,756	32,300	31,305	30,126
National enhanced services (GMS)	7,878	9,549	5,288	6,732	3,333
Local enhanced services	13,452	14,399	13,265	14,836	23,069
Total enhanced services	42,771	48,704	50,853	52,874	56,528

Premises	48,317	40,777	42,384	42,440	42,218
PCO administered funds	15,768	18,548	20,112	23,336	26,578
Out of hours (incl. OOH Development Fund	35,592	36,140	37,537	38,705	40,323
IT (including centrally funded IM and T)	13,548	13,900	16,899	14,987	14,000
Total other payments	113,225	109,365	116,932	119,468	123,119
Subtotal	461,220	474,765	505,721	522,588	536,142

Country specific investment
National primary care fund: direct practice payments		5,434	5,796	5,155	4,858
National primary care fund: Investment on behalf of GP practices		14,266	20,685	22,014	22,412
Total country specific investment		19,700	26,481	27,169	27,270

Total net of dispensing	461,220	494,465	532,202	549,757	563,412

Cost of dispensing fees (including DSQS) (1)	12,288	11,894	12,785	12,024	14,289
Total investment excluding reimbursement of drugs (2)	473,508	506,359	544,987	561,781	577,701
Reimbursement of dispensed drugs (incl. vat allowance and discounts)	37,767	37,500	38,307	40,196	39,461
Total spend (3)	511,275	543,859	583,294	601,977	617,162

In 2020/21 there was an increase in the total investment in GP practices of £15.1 million compared to the published 2019/20 figures.

For items dispensed and/or personally administered by dispensing doctors and prescribing doctor practices.
Total investment excluding reimbursement of drugs is the total including the cost of dispensing fees but not including reimbursement of the cost of drugs.
For 2017 to 18 and 2018 to 19 includes costs for one APMS contract.

Note:

Negative figures can arise when previous year-end accruals are higher than the actual expenditure that then subsequently arises in the following financial year, which would explain any apparently negative expenditure.
National primary care fund expenditure: prior to 2017-18, was only added as a footnote.

Table 2b: Reported Investment in general practice 2020 to 2021
	£ thousands
	Outturn
Global sum	304,906
MPIG correction factor	3,958
Total global sum and MPIG	308,864

Quality aspiration payments	9,927
Quality achievement payments	5,164
Quality assurance improvement framework (QAIF)	23,828
QAIF (In hours Access)	8,712
Total quality	47,631

Direct enhanced services	30,126
National enhanced services	3,333
Local enhanced services	23,069
Total enhanced services	56,528

Premises	42,218
PCO administered funds	26,578
Out of hours	40,323
IM and T	14,000
Total other payments	123,119
Subtotal	536,142
Country specific investment
National primary care fund: direct practice payments	4,858
National primary care fund: Investment on behalf of GP practices	22,412
Total country specific investment	27,270

Total net of dispensing	563,412

Dispensary Services Quality Scheme (DSQS)	493
Cost of dispensing fees (including DSQS) (1)	13,796
Total of all dispensing fees	14,289

Total investment excluding reimbursement of drugs (2)	577,701
Reimbursement of dispensed drugs (incl. vat allowance and discounts)	39,461
Total spend	617,162

For items dispensed and/or personally administered by dispensing doctors and prescribing doctor practices.
Total Investment excluding reimbursement of drugs is the total including the cost of dispensing fees but not including reimbursement of the cost of drugs.

Note:

Negative figures can arise when previous year-end accruals are higher than the actual expenditure that then subsequently arises in the following financial year, which would explain any apparently negative expenditure.
National primary care fund expenditure: prior to 2017-18, was only added as a footnote.

Table 2c: Supplementary information 2019 to 2020
	£ thousands
	Outturn
Direct enhanced services
Asylum seekers and refugees	2
Care of diabetes	1,045
Care homes	3,561
Childhood vaccination and immunisation scheme	6,044
Extended opening times	694
Homeless	56
Influenza and pneumococcal immunisations scheme	11,249
Learning disabilities	294
Mental health	58
Minor surgery fees	2,348
Services for violent patients	168
Oral anticoagulation with Warfarin	4,586
Gender identity	21
Total direct enhanced services	30,126
PCO administered funds
Seniority	5,502
Doctors retainer scheme payments	421
Locum allowances consisting of:
a) Adoptive, paternity and maternity	2,804
b) Sickness	1,557
c) Suspended doctors	326
d) Other locum payments	52
Appraiser costs
Recruitment and retention (incl. golden hello)	23
Primary care development scheme	1,784
Partnership premium	4,303
Designated area allowance
Initial practice allowance
Assistant's allowance
Associate allowance
Supply of syringes and needles
Pneumococcal (campaign and catch up)
Other	9,806
Total PCO administered funds	26,578
Other payments
GP support costs	451
Managed practice costs - managed practices	8,546
Managed practice costs - managing practices
Primary care initiatives
GP practice training	67
Translation service costs
Other approved PCO administered costs	742
Total other payments	9,806

Note:

Negative figures can arise when previous year-end accruals are higher than the actual expenditure that then subsequently arises in the following financial year, which would explain any apparently negative expenditure.

This file may not be fully accessible.